
Purdue Pharma’s newly created subsidiaries raise questions over attempts to shield assets from bankruptcy
DOUGLAS HEALEY/AP
In recent months, Purdue launched two limited partnerships that are marketing or developing drugs previously listed as part of the Purdue product portfolio.


No hay comentarios:
Publicar un comentario